Početna › Limfom › Texas › Dallas
Kliničke studije za Limfom u gradu Dallas, TX
10 studija za Limfom traži sudionike na lokacijama u gradu Dallas i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
U tijeku regrutacijaFaza 1/2
- Baylor Scott & White Research Institute, Texas Oncology, Dallas
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
U tijeku regrutacijaFaza 1/2
- The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
U tijeku regrutacijaFaza 1/2
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
U tijeku regrutacijaFaza 1/2
- Baylor Scott & White Health, Dallas
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
U tijeku regrutacijaFaza 1/2
- Baylor University Medical Center, Dallas
DALY II USA/ MB-CART2019.1 for DLBCL
U tijeku regrutacijaFaza 2
- UT Southwestern Medical Center, Dallas
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
U tijeku regrutacijaFaza 1/2
- Call for Information (Investigational Site 0054), Dallas
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
U tijeku regrutacijaOpažajna studija
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
U tijeku regrutacijaFaza 1/2
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
U tijeku regrutacijaFaza 1
- UT Southwestern Medical Center, Dallas
Studije za Limfom u drugim gradovima
- Houston, TX34 studija
- Boston, MA33 studija
- New York City, NY33 studija
- Washington, DC23 studija
- Baldwin Park, CA21 studija
- Chicago, IL20 studija
- Durham, NC17 studija
- St. Louis, MO15 studija
- Philadelphia, PA15 studija
- Cleveland, OH14 studija
- Edison, NJ12 studija
- Atlanta, GA12 studija
Ostale studije u gradu Dallas
- Rak dojke55 studija
- Nemikrocelularni karcinom pluća52 studija
- Metastatski karcinom42 studija
- Srčano zatajenje42 studija
- Rak (sve vrste)37 studija
- Rak prostate36 studija
- Kolorektalni rak33 studija
- Debljina30 studija
- Rak jajnika28 studija
- Rak mjehura27 studija
- Rak pluća27 studija
- Rak endometrija24 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.